Efficacy and kinetics of glycerol inactivation of HIV-1 in split skin grafts

Journal of Medical Virology

Volumn 60, Issue 2, 2000, Pages 182-188

  Cameron, Paul U ^c   Pagnon, Joanne C ^c   Van Baare, Jeroen ^a   Reece, Jeanette C ^c   Vardaxis, Nicholas J ^c   Crowe, Suzanne M ^b  

^a RED CROSS HOSPITAL   (Netherlands)

^b MACFARLANE BURNET INSTITUTE FOR MEDICAL RESEARCH AND PUBLIC HEALTH   (Australia)

^c NONE

Author keywords

Glycerol; Skin graft; Virus inactivation

Indexed keywords

GLYCEROL;

ARTICLE; BURN; CONCENTRATION RESPONSE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN TISSUE; SEROPREVALENCE; SKIN GRAFT; SPLIT THICKNESS SKIN GRAFT; TEMPERATURE DEPENDENCE; VIRUS INACTIVATION; VIRUS ISOLATION;

CADAVER; DISINFECTANTS; GLYCEROL; HIV-1; HUMANS; SKIN; TEMPERATURE; TRANSPLANTS;

DNA VIRUSES; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0033987550     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9071(200002)60:2<182::AID-JMV13>3.0.CO;2-Y     Document Type: Article

References (24)

1. Cameron PU, Lowe MG, Sotzik F, Coughlan A, Crowe SM, Shortman K. 1996. Interactions of macrophage-tropic and non-macrophage-tropic isolates of HIV-1 with thymic and tonsillar dendritic cells in vitro. J Exp Med 183:805-811.
2. Clarke JA. 1987. HIV transmission and skin grafts. Lancet 1:983
3. Compton CC, Kupper TS, Nadire KB. 1996. HIV-infected Langerhans Cells constitute a significant proportion of the epidermal Langerhans Cell population throughout the course of HIV disease. J Inv Dermatol 107:822-826.
4. de Backere AC. 1994. Euro Skin Bank: large scale skin-banking in Europe based on glycerol-preservation of donor skin. Burns 20(Suppl 1):S4-S9.
5. de Jong JC, Harmsen M, Trouwborst T. 1975. Factors in the inactivation of Encephalomyocarditis virus in aerosols. Inf Imm 12:29-35.
6. Druce JD, Jardine D, Locarnini SA, Birch CJ. 1995. Susceptibility of HIV-1 to inactivation by disinfectants and ultraviolet light. J Hosp Inf 30:167-180.
7. Eastlund T. 1995. Infectious disease transmission through cell, tissue, and organ transplantation: reducing the risk through donor selection. Cell Transplant 4:455-477.
8. Gordon V, Parry S, Bellamy K, Osborne R.1993. Assessment of chemical disinfectants against human immunodeficiency virus: overcoming the problem of cytotoxicity and the evaluation of selected actives. J Virological Meth 45:247-257.
9. Hanson PJV, Gor D, Jeffries DJ, Collins JV. 1989. Chemical inactivation of HIV on surfaces. Br Med J 298:862-864.
10. Hettich R, Ghofrani A, Hafemann B. 1994. The immunogenicity of glycerol-preserved donor skin. Burns 20:S71-S76.
11. Kornbluth RS.1994. Significance of T cell apoptosis for macrophages in HIV infection. J Leukocyte Biol 56:247-256.
12. Marshall L, Ghosh MM, Boyce SG, MacNeil S, Freedlander E, Kudeisa G. 1995. Effect of glycerol on intracellular virus survival: implications for the clinical use of glycerol-preserved cadaver skin. Burns 21:356-361.
13. McMaster P, Mirza P. 1995. Precautions to prevent transmission of infectious agents in organ grafting.In: Englbert Y, editor. Organ and tissue transplantation in the European Union: management of difficulties and health risks linked to donors. Dorrecht, Netherlands: Martinus Nijhof, p 28.
14. Palacio J, Souberbiele BE, Shattock RJ, Robinson G, Manyonda I, Griffin GE. 1994. In vitro HIV-1 infection of human cervical tissue. Res Virol 145:155-161.
15. Ramarli D, Giri A, Reina S, Poffe O, Cancedda R, Varnier O, Tridente G, De Luca M. 1995. HIV-1 spreads from lymphocytes to normal human keratinocytes suitable for autologous and allogenic transplantation. J Inv Dermatol 105:644-647.
16. Reece JC, Handley AJ, Anstee EJ, Morrison WA, Crowe SM, Cameron PU. 1998. HIV-1 selection by epidermal dendritic cells during transmission across human skin. J Exp Med 187:1623-1631.
17. Reed LJ, Muench H. 1938. A simple method of estimating fifty percent endpoints. Am J Hyg 27:493
18. Richters CD, Hoekstra MJ, van Baare J, Du Pont JS, Kamperdijk EW. 1996. Morphology of glycerol-preserved human cadaver skin. Burns 22:113-116.
19. Simonds RJ, Holmberg SD, Hurwitz RL, Coleman TR, Bottenfield S, Conley LJ, Kohlenberg SH, Castro KG, Dahan BA, Schable CA, Rayfield MA, Rogers MF. 1992. Transmission of Human Immunodeficiency Virus type 1 from a seronegative organ and tissue donor. N Engl J Med 326:726-732.
20. van Baare J, Buitenwerf J, Hoekstra MJ, Du Pont JS. 1994. Virucidal effect of glycerol as used in donor skin preservation (see comments). Burns 20(Suppl 1):S77-80.
21. Willey RL, Smith DH, Lasky LA, Theodore TS, Earl PL, Moss B, Capon DJ, Martin MA. 1988. In vitro mutagenesis identifies a region within the envelope gene of the human immunodeficiency virus that is critical for infectivity. J Virol 62:139-147.
22. Wolff KD, Dienemann D. 1990. Vessel preservation with glycerol: an experimental study with rats. J Oral Maxillofacial Surg 48:914-918.
23. Zaitseva M, Blauvelt A, Lee S, Lapham CK, Klauskovtun V, Mostowski H, Manischewitz J, Golding H. 1997. Expression and function of CCR5 and CXCR4 on human Langerhans Cells and macrophages -implications for HIV primary infection. Nature Med 3: 1369-1375.
24. Zambruno G, Mori L, Marconi A, Mongiardo N, De Rienzo B, Bertazzoni U, Giannetti A. 1991. Detection of HIV-1 in epidermal Langerhans Cells of HIV-1 infected patients using Polymerase Chain Reaction. J Inv Dermatol 96:979-982.